What drove the pre-market jump in MEDICO.BO stock today?

The pre-market jump to INR 53.53 came on a 19.75% price rise and volume of 48,776 shares. Early buying outpaced average volume, suggesting short-term momentum. The Feb 3, 2026 earnings date and export demand in the specialty generics sector are likely catalysts.

What valuation metrics matter for MEDICO.BO analysis?

Key metrics: P/E **35.89**, P/B **6.11**, ROE **18.35%**, net margin **6.61%**, and current ratio **1.62**. These show profitability but relatively high price multiples versus sector peers, increasing sensitivity to earnings.

What are realistic MEDICO.BO stock price targets?

Meyka AI's model projects a monthly target of **INR 62.22** (+16.23% vs INR 53.53). Quarterly model is **INR 48.23** (-9.90%) and yearly is **INR 46.13** (-13.82%). These are model projections, not guarantees.

Should investors buy MEDICO.BO after this pre-market move?

Given mixed technicals and stretched valuation, consider waiting for earnings confirmation on Feb 3, 2026, or buying in tranches with tight stops. The Meyka grade is B (HOLD), signalling caution alongside selective accumulation.

IN Stocks

MEDICO.BO Medico Remedies BSE up 19.75% pre-market Jan 24 2026: watch INR 62.22

ByHuzaifa Zahoor January 24, 2026January 24, 2026

MEDICO.BO stock jumped 19.75% in pre-market trade on Jan 24, 2026, trading at INR 53.53 after opening at INR 50.99. The move came on a volume spike to 48,776 shares, nearly 2.82x the average volume of 12,580, signalling heavy buyer interest. For traders focused on top gainers, Medico Remedies Limited (MEDICO.BO) on the BSE shows a clear short-term momentum shift, but fundamentals and upcoming earnings on Feb 3, 2026, should govern follow-through. We unpack price action, ratios, technicals, Meyka AI grading, and model forecasts to frame trading and investment scenarios.